October 5, 2010Journal of Cardiovascular Pharmacology and Therapeutics
Review: Antiplatelet Therapy in Acute Coronary Syndromes
Population
Patients with acute coronary syndromes (ACS) and those undergoing percutaneous coronary intervention (PCI)
Design
Review
Authors
Discussion
Loading...
Member takes
Implication
Offers synthesis of antiplatelet options in ACS/PCI; leaves open optimal regimens with newer agents.
Structured PICO
P
Population
Patients with acute coronary syndromes (ACS) and those undergoing percutaneous coronary intervention (PCI)
I
Intervention
Antiplatelet therapy (aspirin, ADP-receptor blockers, glycoprotein IIb/IIIa inhibitors, novel ADP-receptor blockers, thrombin inhibitors)
This article provides a comprehensive review of antiplatelet therapies, including aspirin, ADP-receptor blockers, and glycoprotein IIb/IIIa inhibitors, for the management of acute coronary syndromes and PCI.
Cite This Study
Aragam et al. (2010) studied this question.